Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017.

Raphael SonabendWilliam E HenleyAndrew P McGovernAndrew J FarmerNaveed SattarRury R HolmanEwan R PearsonAndrew T HattersleyBeverley M ShieldsAngus G Jonesnull null

Published in: Diabetes, obesity & metabolism (2019)

Recent changes in prescribing of therapy for people with type 2 diabetes have not led to a change in glycaemic response and have resulted in modest improvements in other population-level short-term clinical outcomes.

Keyphrases

primary care
type diabetes
risk factors
glycemic control
insulin resistance
electronic health record
cardiovascular disease
general practice
emergency department
metabolic syndrome
adipose tissue
weight loss
artificial intelligence